Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Yu Long ^a   Feng, Shou Hao ^a   Zhu, Ji ^a   Zhu, Guo Pei ^a   Li, Duan Shu ^a   Wang, Yu ^a   Zhu, Yong Xue ^a   Sun, Guo Hua ^a   Ji, Qing Hai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOPHARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PREDICTION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM;

EID: 84874220527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056613     Document Type: Article

References (26)

1. Ligier K, Belot A, Launoy G, Velten M, Bossard N, et al. (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. Oral Oncol 47: 302-307.
2. Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, et al. (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34: 270-281.
3. Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, et al. (2011) National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Head and neck cancers. J Natl Compr Canc Netw 9: 596-650.
4. Suarez C, Rodrigo JP, Silver CE, Hartl DM, Takes RP, et al. (2012) Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. Head Neck.
5. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, et al. (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27: 843-850.
6. Spillane AJ, Cheung BL, Winstanley J, Thompson JF, (2011) Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg 253: 109-115.
7. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, et al. (2009) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27: 1062-1068.
8. Wang W, Xu DZ, Li YF, Guan YX, Sun XW, et al. (2011) Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a single-institution study of 1343 Chinese patients. Ann Oncol 22: 2049-2056.
9. Ceelen W, Van Nieuwenhove Y, Pattyn P, (2010) Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol 17: 2847-2855.
10. Deng J, Sun D, Pan Y, Zhang L, Zhang R, et al. (2012) Ratio between Negative and Positive Lymph Nodes Is Suitable for Evaluation the Prognosis of Gastric Cancer Patients with Positive Node Metastasis. PLoS One 7: e43925.
11. Gao P, Song YX, Wang ZN, Xu YY, Tong LL, et al. (2012) Integrated ratio of metastatic to examined lymph nodes and number of metastatic lymph nodes into the AJCC staging system for colon cancer. PLoS One 7: e35021.
12. Song YX, Gao P, Wang ZN, Tong LL, Xu YY, et al. (2012) Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes? PLoS One 6: e28937.
13. Kotwall C, Sako K, Razack MS, Rao U, Bakamjian V, et al. (1987) Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154: 439-442.
14. Surveillance, Epidemiology and End Results (SEER) website. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R,et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD. Based on November 2010 SEER data submission, posted to the SEER web site, 2011. Available: http://seer.cancer.gov/csr/1975_2008/. Accessed 2011 Oct 7.
15. Vinh-Hung V, Joseph SA, Coutty N, Ly BH, Vlastos G, et al. (2010) Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologist 15: 1050-1062.
16. Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, et al. (2012) Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255: 478-485.
17. Camp RL, Dolled-Filhart M, Rimm DL, (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259.
18. Bradburn MJ, Clark TG, Love SB, Altman DG, (2003) Survival analysis Part III: multivariate data analysis - choosing a model and assessing its adequacy and fit. Br J Cancer 89: 605-611.
19. Harrell FE Jr, Lee KL, Mark DB, (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
20. The R Project for Statistical Computing websit. R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available: http://www.R-project.org/. Accessed 2012 Dec 7.
21. Glynn RW, Lowery AJ, Scutaru C, O'Dwyer T, Keogh I, (2012) Laryngeal cancer: Quantitative and qualitative assessment of research output, 1945-2010. Laryngoscope 122: 1967-1973.
22. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, et al. (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116: 1-13.
23. Chen AY, Fedewa S, Zhu J, (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 137: 1017-1024.
24. Bernier J, Cooper JS, (2005) Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist 10: 215-224.
25. Bisdas S, Nguyen SA, Anand SK, Glavina G, Day T, et al. (2009) Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 73: 1313-1318.
26. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Mancuso AA, (2003) Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 25: 535-542.